Physician profile
Deborah B Patterson
NPI 1255429668
$963.70
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2021: $694.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $271.40 | 2019-2021 | |
| Journey Medical Corporation | $188.28 | 2021 | |
| Vyne Pharmaceuticals INC. | $135.95 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $112.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $70.29 | 2021 | |
| Abbvie INC. | $48.99 | 2021 | |
| Amgen INC. | $39.24 | 2021 | |
| Sandoz INC. | $21.82 | 2021 | |
| Leo Pharma INC. | $17.11 | 2021 | |
| Nabriva Therapeutics, Plc | $16.65 | 2021 | |
| Taro Pharmaceuticals USA, INC. | $12.42 | 2019 | |
| Lilly USA, LLC | $12.32 | 2021 | |
| Galderma Laboratories, L.P. | $12.32 | 2021 | |
| Biofrontera INC. | $4.05 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.